Skip to main content
CDC Website

Next Generation Multipurpose Prevention Technologies

The objective of this Funding Opportunity Announcement (FOA) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic) multipurpose prevention technologies (MPTs). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy; or multiple non-HIV STI or HIV/STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development, and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety, and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use.

Funding Organization:
The US Department of Health and Human Services National Institutes of Health
Funding Category:
HIV/AIDS
Other Health-Related
STD
Support Types:
Discretionary Grants
Locations:
National
Fund Number:
365195
Fund ID:
PAR-22-222
Application Due Date:
Subjects:
Clinical Research
HIV
HIV and AIDS Prevention
Research
STD/STI Prevention
Audiences:
At Risk Persons
Persons with HIV/AIDS
Persons with STD/STI
Researchers
Last Updated:
Application Contact
Ann
Devine
National Institute of Allergy and Infectious Disease (NIAID)
240-669-2988
adevine@niaid.nih.gov
Technical Contact
Rita
Sisco
301-443-2805
siscor@mail.nih.gov